Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × Imiquimod × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Breast 1

Conditions

Breast Neoplasms 5 Stomach Neoplasms 1 Breast Neoplasms, Male 1

Interventions

pembrolizumab 24 Paclitaxel 14 Trastuzumab 13 Docetaxel 10 Cyclophosphamide 10 Capecitabine 10 Nivolumab 8 Carboplatin 7 fludarabine 6 Oxaliplatin 6 Magnetic Resonance Spectroscopy 5 Leucovorin 5 Irinotecan 5 Injections 5 Fluorouracil 5 Cisplatin 5 Bevacizumab 5 aldesleukin 4 Taxes 4 Specimen Handling 4 Ipilimumab 4 Fluorodeoxyglucose F18 4 zanidatamab 3 veliparib 3 tucatinib 3 trastuzumab deruxtecan 3 sargramostim 3 durvalumab 3 budigalimab 3 atezolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02276300 2019-11-20

HER2

Technical University of Munich

Phase 1 Completed

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡